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Abstract: A method for the synthesis of tyrosine, phenyl alanine, hydroxy 
proline and threonine free amino acid analogues of 5H-dibenz[b,f]azepine is 
proposed. 5H-dibenz[b,f]azepine was prepared by known method. The key 
intermediate 3-chloro-1-(5H-dibenz[b,f]azepine-5-yl)propan-1-one was obtained 
by N-acylation of 5H-dibenz[b,f]azepine with 3-chloro propionyl chloride. 
Further coupling of respective free  amino acid to produce 2-(3-(5H-
dibenz[b,f]azepine-5-yl)-3-oxopropylamino)3-(4 hydroxyphenyl) propanoic acid, 
2-(3-(5H-dibenz[b,f]azepine-5-yl)-3-oxopropylamino)-3-phenyl propanoicacid,1-
(3-(5H-dibenz[b,f] azepine-5-yl)-3-oxopropyl)-3-hydroxypyrolidine-2-carboxylic 
acid and 2-(3-(5H-dibenz[b,f] azepine-yl)-3-oxopropyl amino)-3-hydroxy 
butanoic acid. The synthesized compounds were evaluated for their potential over 
1,1-diphenyl-2-picryl hydrazyl (DPPH) free radical scavenging activity. 
Butylated hydroxy anisole (BHA) and ascorbic acid (AA) were used as the 
reference antioxidant compounds and also the comparative study with 
synthesized compounds was done. Under our experimental conditions tyrosine, 
hydroxy proline and threonine analogues possess a direct scavenging effect on 
trapping the stable free radical DPPH. Hydroxy proline analogues showed a 
significant radical scavenging activity among the synthesized analogues. 
Keywords: 5H-dibenz[b,f]azepine, 3-Chloro-1-(5H-dibenz[b,f]azepine-5-yl) propan-1-one, Amino 
acid, Radical scavenging activity. 
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Introduction 
Free radicals can have a noxious effect on cells and it is believed that free radical damage 
is involved in the etiology of several diseases. The radicals are a by-product of various 
endogenous processes that can be stimulated by external factors, such as irradiation and 
xenobiotics1. Antioxidants protect against these radicals, and it is important to balance an 
enhanced radical production with a sufficient supply of antioxidants. There are two basic 
categories of antioxidants, namely, synthetic and natural. The most common synthetic 
antioxidants used in foods are compounds with phenolic structures of various degrees of 
substitution, whereas natural antioxidants are primarily plant phenolics and polyphenolic 
compounds that may occur in all the parts of plants2. Most of the antioxidants in use 
commercially e.g., butylated hydroxy anisole (BHA), butylated hydroxy toluene (BHT) and 
propyl gallate (PG) are synthetic3. Considerable progress has been made in recent years 
relating free radicals, especially reactive oxygen species in living cells to pathogenecity of 
various diseases4-5 including hepatic and vascular diseases6-7. Efforts to discover antioxidants 
as useful drug candidates to combat these diseases are going on relentlessly. Numerous 
natural or synthetic antioxidant compounds have been tested with success in various disease 
models as well as in clinics8. Antioxidants are now forged as the drug candidate to combat 
these diseases. In the literature some tricyclic amines and their chemical structure shows 
antioxidant neuroprotective activity in vitro9. 5H-dibenz[b,f]azepine i.e., iminostilbene is a 
common a basic fused tricyclic amine. It is used as an intermediate for the synthesis of the 
registered anticonvulsant drug oxcarbazepine10. The structure of which has recently been 
reported11. Dibenz[b,f]azepine and its derivatives has been variously reported as having 
antiallergic activity, specifically antihistaminic activity, spansmolytic, serotonin 
antagonistic, anticonvulsive, antiemetic, antiepileptic, anti inflammatory, sedative and 
fungicidal action12. As a part of a series of studies into activity aspects, the radical 
scavenging activity of amino acid analogues of 5H-dibenz[b,f]azepine was determined and is 
reported here. The research on free radicals provides theoretical information for the 
medicinal development, and supplies some in vitro methods for quick optimizing drugs, it 
attracts more scientific attention from bioorganic and medicinal chemists. In addition to the 
traditional O-H bond type antioxidant, tricyclic amines having N-H bond functions as the 
antioxidant have attracted much research attention because aromatic amines (Ar2NHs) have 
always been the central structure in many currently used drugs13. From the literature amino 
acids and some of their derivatives were also found to have antioxidant activity14. 
 In the present paper we have used a model compound 3-chloro-1-(5H-dibenz[b,f] 
azepine-5-yl) propan-1-one to verify the possibility of obtaining the amino acid analogues of 
5H-dibenz[b,f]azepine. Since their structure may justify a possible intervention on free 
radical process we have selected some of the free amino acids to explore better the 
chemistry and biological activities. The amino acid analogues were synthesized and their 
structure was established by chemical and spectral analysis. The compounds were 
investigated for in vitro DPPH free radical scavenging potential and the activity was 
compared to commercially available synthetic antioxidants namely butylated hydroxy 
anisole (BHA) and ascorbic acid (AA). A number of methods are available for the 
determination of free radical scavenging activity but the assay employing the stable 1,           
1-diphenyl picryl hydrazyl radical (DPPH) has received most attention owing to its ease of 
use and its convenience15. This assay is the most widely used in vitro test through which to 
assess free radical scavenger capacities16. These studies may reflect the possibility for 
therapeutic uses and as a source of synthetic antioxidants. 
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 5H-Dibenz[b,f]azepine was synthesized by applying known method10. The synthesis of 
amino  acid analogues of 5H-dibenz[b,f]azepine was  realized in two steps. First step the key  
intermediate 3-Chloro-1-5H-dibenz[b,f]azepine-5-yl) propan-1-one was prepared in good 
yield by N-acylation of 5H-dibenz[b,f]azepine with 3-chloro propionyl chloride in the 
presence of triethyl amine as base (Scheme 1). In the second step further coupling of 
respective amino acid to the intermediate were done to obtain the amino acid analogues of 
5H-dibenz[b,f]azepine (Scheme 2). 
 
 
 
 
 
 
Scheme 1 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Scheme 2 
Experimental 
The following compounds and materials supplied by Sigma Aldrich were used: tyrosine, phenyl 
alanine, hydroxy proline, threonine. All the aminoacids used in the study were of                   
L-configuration. Reagents and solvents like 3-chloro propionyl chloride, triethyl amine, 
benzene, methanol, chloroform, diethyl ether, acetic acid, ethyl acetate, sodium bicarbonate, 
anhydrous sodium sulphate were all of analytical grade and procured from Merck. TLC 
aluminium sheets silica gel 60 F254 was also purchased from Merck. 
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 The IR spectra were recorded on a FT-IR021 model in KBr disc. The 1H NMR spectra 
were recorded on Jeol GSX 400 MHz spectrophotometer using CDCl3 as a solvent and the 
chemical shift (δ) are in ppm relative to internal standard. The mass spectra were recorded 
on Waters-Q-TOF Ultima spectrophotometer.  
Synthesis of 3 -chloro -1-(5H-dibenz[b,f]azepine-5-yl) propan-1-one 
To the well stirred solution of 5H- dibenz[b,f]azepine (2 mM) and  triethyl amine (2.2 mM) in 
50 mL benzene, 3- chloro propionyl chloride (2.2 mM) in 25 mL benzene was added drop by 
drop for about 30 min.  Then the reaction mixture is stirred at room temperature for about 6 h. 
Progress of the reaction is monitored by TLC using 9:1 Hexane: Ethyl acetate mixture as 
mobile phase. After the completion of reaction, the reaction mass was quenched in ice cold 
water and extracted in diethyl ether. The ether layer was washed twice with 5% NaHCO3 and 
once with distilled water. Finally the ether layer is dried with anhydrous Na2SO4. The light 
yellow crystal solid product was obtained by desolventation through rota vapour at 50 0C. 
 Light yellow solid, Yield (85%), M.p. 109-1100C, IR (KBr): 3067.9 (Ar C-H), 1675.3 
(C=O), 2971.0- 3026.1 (CH2) cm-1; 1H NMR (CDCl3): δ 2.8 (d, 2H, CH2 – CO), 3.7 (d, 2H, 
CH2Cl), 7.5 (m, 6H, Ar – H), 7.6 (d, 2H, C4, C6 of Ar – H), 6.9 (d, 2H, C10, C12 of Ar – H); 
Mass (m/z % abundance): 284.56 (M+, 98), 286.57 (35), 278.61 (2), 279.64 (2); Anal. Calcd. 
for C17H14ClNO: C, 71.96; H, 4.97; Cl, 12.49; N, 4.94; O, 5.64%; Found: C, 71.20; H, 4.88; 
Cl, 12.26; N, 4.79; O, 5.52%    
Synthesis of 3-(4-hydroxyphenyl)-2-(3-(5H-dibenz[b,f]azepine-5-yl)-3-oxopropylamino) 
propanoic acid 
Tyrosine (1.2 mM) in methanol (25 mL) was neutralized with triethyl amine (1.2 mM). To 
this, K2CO3 (600 mg) was added. Later the solution of 3-chloro-1-(5H-dibenz[b,f]azepine-5-
yl) propan-1-one  (1 mM)  in   methanol   (50 mL)   was   added   drop  by  drop  for  30 min.  
The reaction mixture was refluxed for 6-8 h. The progress of the reaction mixture was 
monitored by TLC.  The reaction mixture was then desolventized in rota vapour and the 
compound is extracted in ethyl acetate. The ethyl acetate layer was washed with water and 
dried over anhydrous Na2SO4. The light yellow solid was obtained by further desolventation 
in rota vapour at 50oC. 
 Phenyl alanine, hydroxy proline and threonine amino acid analogues of 5H-dibenz 
[b,f]azepine were obtained by the same procedure. The analogues were separated and 
purified by column chromatography, using mixture of chloroform / methanol / acetic acid = 
85: 15: 3. The products were characterized by IR, Mass 1H NMR and Elemental Analysis. 
Synthesis of 3-(4-hydroxyphenyl)-2-(3-(5H-dibenz[b,f]azepin-5-yl)-3-oxopropylamino) 
propanoic acid 
Light yellow solid, Yield (72%), M.p. 91-930C, IR (KBr): 2467.0-3390.2 (OH-
carboxylic acid), 3023.1 (Ar-C-H), 3316.5 (N-H), 1679.0 (C=O), 2812.0-2836.0 (CH2) 
Cm-1; 1H NMR (CDCl3): δ 2.12 (d, 2H, CH2 – CO), 2.58 (d, 2H, CH2-N), 3.2 - 3.5 (m, 
2H,  benzylic  CH2 & t, 1H, CH – N), 6.8 (s, 2H, Ar – H, ortho to OH of tyrosine), 7.0 
(s, 2H, C10, C11 of Ar – H), 7.1 (s, 2H, Ar – H, para to OH of tyrosine), 7.35 – 7.54 (m, 
8H, Ar – H), 9.5 (s, 1H, OH of tyrosine), 11.5 (s, 1H, carboxylic OH), 2.0 (s, 1H, NH); 
Mass (m/z % abundance): 427.84 (M+ 97), 424.10 (50), 421.21 (2), 419.28 (35). Anal. 
Calcd. for C26H24N2O4: C, 72.88; H, 5.65; N, 6.54; O, 14.94%; Found:  C, 72.12; H, 
5.49; N, 6.78; O, 14.01%. 
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2-(3-(5H-dibenz[b,f]azepine-5-yl)-3-oxopropylamino)-3-phenyl propanoicacid 
Light yellow solid, Yield (73%), M.p. 84-860C, IR (KBr): 2572.6-3191.5 (OH-carboxylic 
acid), 3021.9 (Ar-C-H), 3317.8 (N-H), 1678.9 (C=O), 2884.7-2918.0 (CH2) Cm-1; 1H NMR 
(CDCl3): δ 2.12 (d, 2H, CH2 – CO), 2.58 (d,  2H, CH2-N), 3.2 - 3.5 (m, 2H, benzylic  CH2 & t, 
1H, CH – N), 7.0 (s, 2H, C10, C11 of Ar – H), 7.35 – 7.54 (m, 13H, Ar – H), 11.5 (s, 1H, 
carboxylic OH), 2.0 (s, 1H, NH); 
 Mass (m/z % abundance): 409.14 (M+ 98), 410.14 (9), 413.14 (3); Anal. Calcd. for 
C26H24N2O3: C, 75.71; H, 5.86; N, 6.79; O, 11.64%; Found: C, 75.54; H, 6.12; N, 6.42; O, 11.99%. 
1-(3-(5H-dibenz[b,f]azepine-5-yl)-3-oxopropyl)-3-hydroxypyrolidine-2-carboxylic acid 
Light yellow solid, Yield (74%), M.p. 82-840C, IR (KBr): 2572.0-3261.6 (OH-carboxylic 
acid), 3021.3 (Ar-C-H), 3320.1 (N-H), 1669.9 (C=O), 2895.9(CH2) Cm-1; 1H NMR (CDCl3): 
δ 2.0 - 2.5 (t, 2H, CH2CO, and m, 2H, CH2N), 2.58 (d, 2H, CH2 – N of pyrolidine), 1.7 (d,  
2H, CH2 of pyrolidine), 4.80 (s, 1H, OH of pyrolidine), 3.8 (m, 1H, CH-OH),  3.1 (d, 1H, 
CH of carboxylic acid), 11.5 (s, 1H, carboxylic OH), 7.35 – 7.54 (m, 8H, Ar – H), 7.0 (s, 
2H, C10, C 11 of Ar – H); Mass (m/z % abundance): 378.23 (M+ 92), 381.22 (3), 392.25 (18), 
393.26 (2); Anal. Calcd. for C22H22N2O4: C, 69.83; H, 5.86; N, 7.40; O, 16.91% ; Found: C, 
70.23; H, 6.17; N, 7.28; O, 16.88%. 
2-(3-(5H-dibenz[b,f]azepine-yl)-3-oxopropyl amino)-3-hydroxy butanoic acid 
Light yellow solid, Yield (78%), M.p. 79-81oC, IR (KBr): 2617.6-3316.8 (OH-carboxylic 
acid), 3022.2 (Ar-C-H), 3361.4 (N-H), 1667.3 (C=O), 3022.2 (CH2) Cm-1;  1H NMR 
(CDCl3): δ 2.12 (d, 2H, CH2CO), 2.6 (d, 2H, CH2N), 2.0 (s, 1H, NH), 3.5 (d, 1H, C H - N), 
3.7 (t, 1H, CH – OH), 5.0 (s, 1H, OH), 1.25 (d, 1H, CH3), 11.5 (s, 1H, COOH), 7.35 – 7.81 
(m, 8H, Ar – H), 7.0 (s, 2H, C10, C 11 of Ar – H); Mass (m/z % abundance): 366.92 (M+ 92), 
365.21 (32), 368.01 (18), 393.26 (2); Anal. Calcd. for C21H22N2O4: C, 68.84; H, 6.05; N, 
7.65; O, 17.47% ; Found: C, 68.34; H, 6.18; N, 7.83; O, 17.21%. 
Radical scavenging activity 
In the present study, the synthesized compounds were screened for their DPPH free 
radical scavenging activity. The compounds were dissolved in distilled ethanol (50 mL) 
to prepare 1000 µM solution. Solutions of different concentrations (10 µM, 50 µM, 100 µM, 
200 µM and 500 µM) were prepared by serial dilution and the free radical scavenging 
activity was studied. 
DPPH radical scavenging activity 
The DPPH (1, 1-diphenyl-2-picrylhydrazyl) radical scavenging effect was carried out 
according to the method first employed by Blois17. Compounds of different concentrations 
were prepared in distilled ethanol, 1mL of each compound solutions having different 
concentrations (10 µM, 50 µM, 100 µM, 200 µM and 500 µM) were taken in different test 
tubes, 4 mL of a 0.1 mM ethanol solution of DPPH was added and shaken vigorously. The 
tubes were then incubated in the dark room at RT for 20 min. A DPPH blank was prepared 
without compound, and ethanol was used for the baseline correction. Changes (decrease) in 
the absorbance at 517 nm were measured using a UV-visible spectrophotometer and the 
remaining DPPH was calculated. The percent decrease in the absorbance was recorded for 
each concentration, and percent quenching of DPPH was calculated on the basis of the 
observed decreased in absorbance of the radical. The radical scavenging activities were 
expressed as the inhibition percentage and were calculated using the formula: 
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Radical scavenging activity (%) = [(A0 – A1 / A0 ) ×100] 
 Where A0 was the absorbance of the control (blank, without compound) and A1 was the 
absorbance of the compound. The radical scavenging activity of BHA and ascorbic acid was 
also measured and compared with that of the different synthesized compound. For all the 
compounds and standards half inhibition concentration (IC50) was calculated and showed in 
the Table 1. 
Results and Discussion 
The starting material 3-Chloro-1-(5H-dibenz[b,f]azepine-5-yl) propan-1-one was prepared in 
good yield by N-acylation reaction. In practice, 5H-dibenz[b,f]azepine and 3-chloro 
propionyl chloride were mixed in 1:1.2 ratio in the presence of  triethylamine as base. The 
reaction was carried out for 6 h at room temperature. The final product was separated from 
the reaction mixture by washing HCl salt (precipitate) with distilled water three times, and 
then the compound was extracted with diethyl ether. The ether layer was washed with 5% 
NaHCO3 for the removal of the remaining quantity of acids. The organic layer was 
separated. The solvent was removed by vacuum -distillation and finally product was isolated 
from coloum chromatography by using 9:1 hexane and ethyl acetate.  
 Amino acid analogues of 5H- dibenz[b,f]azepine were obtained by mixing respective 
amino acid: 3-Chloro-1-(5H-dibenz[b,f]azepine-5-yl) propan-1-one = 1.2 mM: 1 mM. The free 
amino acid was made dissolved in methanol by adding 1-2 mL of triethyl amine, then 600 mg 
of anhydrous K2CO3 was added and stirred for 30 min. 3-Chloro-1-(5H-dibenz[b,f] azepine-5-
yl) propan-1-one in methanol was added drop by drop and refluxed for 6 h. The final product 
was separated from the mixture by desolventation of methanol by vacuum - distillation and 
then the product was extracted with ethyl acetate. Ethyl acetate layer was washed with water to 
remove K2CO3 and dried with anhydrous Na2SO4. Further desolventation by vacuum 
distillation was done and the final product was isolated from column chromatography by using 
chloroform / methanol / acetic acid = 85: 15: 3 as mobile phase. 
 The synthesized compounds were screened for their DPPH free radical scavenging 
activity. The DPPH test provided information about the reactivity of the tested compounds 
with a stable free radical. Because of its odd electron, the DPPH radical showed a strong 
absorption band at 517 nm in visible spectroscopy (a deep purple color). As this electron is 
paired off in the presence of a free radical scavenger, absorbance vanishes and the resulting 
discoloration is stoichiometric with respect to the number of electrons taken up. This bleaching 
of DPPH absorption, which occurs in the odd electron of the radical is paired, is thus 
representative of the capacity of the compounds to scavenge free radicals independently. The 
DPPH free radical scavenging ability for the synthesized compounds is showed in the Figure 1. 
The IC50 or inhibition concentration (IC50) was obtained from the graph of the percentage of 
scavenging radical versus the concentration of antioxidant18-19. Half inhibition concentration 
(IC50) for all the compounds and standards is summarized in the Table 1. 
 Initially, the DPPH free radical scavenging capacity of 3-chloro-1-(5H-dibenz[b,f] azepine-
5-yl) propan-1-one was assessed and found to be not effective. Consequently, molecules with 
amino acid groups were coupled by elimination reaction to enhance the radical scavenging 
activity effect. Further, the test performed with compounds bearing amino acid substituent in the 
chloride position. Tyrosine, hydroxy proline and threonine amino acid analogues are having 
radical scavenging activity with a major activity for hydroxy proline analogues. When tyrosine 
molecule is coupled the activity will be enhanced due to the presence of phenolic group. In the 
case of phenyl alanine, activity disappears due to the absence of –OH group in the aromatic ring.  
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When hydroxy proline is made coupled the RSA increases with a major activity due to the 
presence of –OH group attached to the five member heterocyclic ring i.e., pyrolidine ring. 
Presence of free –OH group in threonine showed the average activity among all the synthesized 
analogues. These results show the major importance of the amino acid substituent in DPPH free 
radical effects. Increasing order of DPPH activity for the synthesized compounds can be 
classified as d. 1-(3-(5H-dibenz[b,f]azepine-5-yl)-3-oxopropyl)-3hydroxypyrolidine-2-
carboxylicacid > b 2-(3-(5H-dibenz[b,f]azepine-5-yl)-3-oxopropylamino)-3-(4-hydroxyphenyl) 
propanoic acid  > e. 2-(3-(5H-dibenz[b,f]azepine-yl)-3-oxopropyl amino)-3-hydroxy butanoic 
acid > c. 2-(3-(5H-dibenz[b,f]azepine-5-yl)-3-oxopropylamino)-3phenylpropanoic acid > a. 3-
chloro-1-(5H-dibenz[b,f]azepine-5-yl) propan-1-one.  
Table 1. 50% Inhibition of DPPH radical by the analogues of dibenz[b,f]azepine.  
    Compound  IC50  µM/mL 
    Compound a         - 
    Compound b 42.17 ± 1.18 
    Compound c         - 
    Compound d 3.01 ± 0.74 
    Compound e 163.59 ± 1.19 
    AA 4.94 ± 0.63 
    BHA 5.26 ± 0.87 
IC50 : Concentration required for 50% reduction of 0.1 mM DPPH radical. 
Values represent means ± SD (n=3). 
where ‘–‘corresponds to negligible activity. 
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Where; a. 3-chloro-1-(5H-dibenz[b,f]azepine-5-yl) propan-1-one  
   b. 2-(3-(5H-dibenz[b,f]azepine-5-yl)-3-oxopropylamino)-3-(4-hydroxyphenyl) propanoic acid, 
   c. 2-(3-(5H-dibenz[b,f]azepine-5-yl)-3-oxopropylamino)-3-phenylpropanoic acid,  
   d. 1-(3-(5H-dibenz[b,f]azepine-5-yl)-3-oxopropyl)-3-hydroxypyrolidine-2-carboxylic acid, 
    e. 2-(3-(5H-dibenz[b,f]azepine-yl)-3-oxopropyl amino)-3-hydroxy butanoic acid,  
  AA. Ascorbic acid, and BHA. Butylated Hydroxy  Anisole. 
Figure 1. DPPH free radical scavenging ability for 3-chloro-1-(5H-dibenz[b,f]azepine-5-yl) 
propan-1-one and its amino acid analogues. Values represent means ± SD (n = 3). 
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 The RSA activity of synthesized compounds was compared to internal standards (AA 
and BHA). Amonge the synthsised compounds tyrosine and hydroxy proline showed more 
effective DPPH activity but slightly less than the standards. It was observed that the RSA 
activity (%) of all the synthesized compounds increase with increase in concentrations. 
Conclusion 
The method proposed by us reproduces the synthesis of amino acid analogues of 5H-dibenz 
[b,f]azepine. The synthesized compounds were characterized with the help of spectroscopic 
techniques and were screened for their ability to DPPH radical scavenging activity. Based on 
the biological assay it was found that the moiety of 3-chloro-1-(5H-dibenz[b,f]azepine-5-yl) 
propan-1-one containing tyrosine, hydroxy proline and threonine showed promising DPPH 
radical scavenging activity. But hydroxy proline analogues were found to be most effective 
radical scavenging activity than the other analogues but slightly less than the internal 
standards (AA and BHA). Our study provides evidence that several amino acid analogues of 
5H-dibenz[b,f]azepine exhibit interesting direct DPPH free radical scavenging activity. 
These effects may be useful in the treatment of pathologies in which free radical oxidation 
plays a fundamental role. 
Acknowledgement 
The authors are thankful to Indian Institute of Science, Bangalore, for providing spectral and 
elemental analysis data of our research compounds. The authors are also thankful to Prof G. 
Nagendrappa, Chairman, DOS in Chemistry, University of Mysore, Manasagangotri, for the 
support and providing the facilities to work. 
References 
1. Halliwell B and Gutteridge J M C, In: Hallwell B, Gutteridge J M C (Eds.), Free 
Radicals in Biology and Medicine, 2nd Edition. Clarendon Press, Oxford., 1989. 
2. Velioglu Y S, Mazza G and Gao L, J Agric Food Chem., 1998, 46, 4113. 
3. Allen J C and Hamilton R J, Rancidity in Foods, 2nd Ed. London, UK: Elsevier 
Applied Science, 1989. 
4. Scott G, Chem Britain, 1995, 879. 
5. Foye W O, Lemke T L and Williams D A. (Eds), Principles of Medicinal Chemisrty   
4th Ed., BI Waverly Pvt Ltd., 1995, 499. 
6. Morel D W, Di Corleto P E and Chisolm G M, Atherosclerosis., 1984, 4, 357. 
7. Heineke J W, Baker L, Rosen H and Chait A, J Clin Invest., 1986, 77, 757. 
8. Rice Evans C A and Diplock A T, Free Radic Biol Med., 1993, 15, 77.  
9. Chirtian Beh L and Bernd moosmann, Free Radic Biol Med., 2000, 33(2), 182.  
10. Krichka L.  J and Ledwith A, Chem Rev., 1974, 74, 101.  
11. Hempel A, Camerman N, Camerman A and Mastropaolo D, Acta Cryst., 2005, E 61, 01313.  
12. Fouche J and Leger A German Patent 1971, 2, 031, 236; Chem. Abstr. 1971, 74, 76346r.  
13. You-Zhi T and Zai-Qun L,   Bioorg Med Chem., 2007, 15, 1903.  
14. Amarowicz R and Shahidi F, Food Chem., 1997, 58, 355.  
15. Sanchez-Moreno C, Larrauri J A and  Saura-Calixto F,  J Sci Food Agric., 1998, 76, 270. 
16. Brand-Williams W, Cuvelier, M E and Berset C, Lebensm-Wiss Technol., 1998, 28, 25-30. 
17. Blois M S,  Nature,  1958, 26, 1199.  
18. Liu Z Q, Luo X Y, Sun Y X, Wu W, Liu C M, Liu Z Q and  Liu S Y,  J Pharm 
Pharmacol., 2004, 56, 1557. 
19. Liu Z Q, Han K, Lin Y J and  Luo X Y,  Biochim Biophys Acta., 2002, 97, 1570.   
Submit your manuscripts at
http://www.hindawi.com
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
Inorganic Chemistry
International Journal of
Hindawi Publishing Corporation 
http://www.hindawi.com Volume 2014
 International Journal ofPhotoenergy
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
Carbohydrate 
Chemistry
International Journal of
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
Journal of
Chemistry
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
Advances in
Physical Chemistry
Hindawi Publishing Corporation
http://www.hindawi.com
 Analytical Methods 
in Chemistry
Journal of
Volume 2014
Bioinorganic Chemistry 
and Applications
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
Spectroscopy
International Journal of
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
The Scientific 
World Journal
Hindawi Publishing Corporation 
http://www.hindawi.com Volume 2014
Medicinal Chemistry
International Journal of
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
 Chromatography  
Research International
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
Applied Chemistry
Journal of
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
Theoretical Chemistry
Journal of
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
Journal of
Spectroscopy
Analytical Chemistry
International Journal of
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
Journal of
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
Quantum Chemistry
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
 Organic Chemistry 
International
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
Catalysts
Journal of
Electrochemistry
International Journal of
Hindawi Publishing Corporation 
http://www.hindawi.com Volume 2014
